About this trial
Exercise echocardiography is a widely used non-invasive test that evaluates cardiac structure and function during physical stress. It provides important information on myocardial ischemia, cardiac performance, hemodynamic responses, and exercise capacity in patients with a broad range of heart diseases. However, real-world prospective data integrating exercise echocardiographic findings across both ischemic and non-ischemic heart disease remain limited.
This prospective observational registry aims to systematically collect clinical, exercise, and echocardiographic data from patients undergoing clinically indicated exercise echocardiography. The registry includes patients with suspected or established ischemic heart disease as well as those with non-ischemic cardiac conditions, such as cardiomyopathies, heart failure, valvular heart disease, and exercise-related symptoms.
The collected data will be used to evaluate exercise-induced changes in cardiac structure and function, identify phenotypes associated with adverse clinical outcomes, and improve risk stratification in routine clinical practice. The registry is observational in nature and does not alter standard clinical care.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Patients referred for clinically indicated exercise echocardiography as part of routine clinical care
Patients evaluated for suspected or known ischemic heart disease, or non-ischemic heart disease, including but not limited to: Cardiomyopathy, Heart failure, Valvular heart disease, Structural heart disease
Ability to perform exercise-based stress testing using treadmill or bicycle protocols
Disqualifiers
Inability to perform exercise testing due to non-cardiac limitations, such as severe orthopedic, neurologic, or pulmonary conditions
Poor echocardiographic image quality that does not allow meaningful interpretation of exercise-induced changes
Any condition deemed by the treating physician to make participation inappropriate or unsafe, even within an observational framework
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.